WISeKey International Holding Ltd Schedules a Conference Call to Discuss the Agenda Items of its 2021 Annual General Meeting of Shareholders Zug, Switzerland, May 6, 2021 - WISeKey International
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO
Pratteln, Switzerland, May 4, 2021 – Santhera .
By Notice of Repurchase Offer dated March 25, 2021 (the
Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the
2017/22 Bonds) on the terms set out in the Notice (the
Exchange
Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation.
S
ettlement
Santhera has decided to settle the Exchange Offer on May 4, 2021. The Exchange Offer will be settled via the banking system. Upon settlement, all offer conditions (b), (c), (d) and (e), as set out in the Notice, which have not been satisfied until that date will be waived.
By Notice of Repurchase Offer dated March 25, 2021 (the
Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the
2017/22 Bonds) on the terms set out in the Notice (the
Exchange
Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation.
S
ettlement
Santhera has decided to settle the Exchange Offer on May 4, 2021. The Exchange Offer will be settled via the banking system. Upon settlement, all offer conditions (b), (c), (d) and (e), as set out in the Notice, which have not been satisfied until that date will be waived.